Susceptibility Gene Detection for Cerebral Infarction Type Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and treating cerebral infarction in the acute phase are challenging due to the difficulty in visually determining the type of cerebral infarction from CT or MRI images, leading to potential miscommunication about the type of infarction during treatment.
Innovation Solution
A cerebral infarction treatment support system that includes a detection device to measure biological samples for the presence of susceptibility genes, a display system in catheter labs and image interpretation rooms, and an image controller to receive and output information related to the susceptibility genes, aiding doctors in identifying the type of cerebral infarction during diagnosis and treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If visual determination of cerebral infarction type is performed by doctors from CT or MRI images, then diagnosis can be performed, but the skill requirement is high and it is difficult to identify the type of cerebral infarction accurately
Solution Approach 1:
The patent introduces a detection device that detects susceptibility genes as an intermediary between the medical images and the diagnosis. This gene detection device provides objective genetic information that mediates the identification process, reducing the skill requirement for doctors while improving accuracy in determining cerebral infarction type.
Solution Approach 2:
The patent replaces the mechanical/visual inspection method with a molecular detection method. Instead of relying on doctors to visually interpret CT or MRI images, the system uses genetic detection mechanisms to identify susceptibility genes, thereby reducing the skill barrier and improving consistency in diagnosis.
2Productivity
If the type of cerebral infarction is orally communicated between doctors, then treatment can proceed quickly, but the certainty is low and there is no means to confirm the type again
Solution Approach 1:
The patent implements a feedback mechanism by detecting susceptibility genes and providing objective confirmation of the infarction type. The detection device provides feedback information that can be verified and confirmed, eliminating the uncertainty of oral communication while maintaining rapid treatment progression.
Solution Approach 2:
The patent performs preliminary gene detection to establish the infarction type before treatment begins. This preliminary action creates a reliable record that can be referenced throughout the treatment process, ensuring continuity and accuracy without requiring repeated oral communications.
3Measurement precision
If gene detection is performed to identify susceptibility genes, then accurate identification of cerebral infarction type is enabled, but additional detection devices and procedures are required
Solution Approach 1:
The patent designs the detection device to serve multiple functions: it detects susceptibility genes, provides diagnostic information, and supports treatment decision-making. This multi-functionality reduces the need for separate specialized devices, as the same device performs multiple roles in the diagnostic and treatment support process.
Data Source
AI summary
A cerebral infarction treatment support system (100) includes a detection device (10), a display (30), and an image controller (20), and the image controller (20) includes a receiver (21) configured to receive at least one of first information (41) generated by the detection device (10) or second information (42) related to a susceptibility gene generated based on the first information (41), and a video output (22) configured to output at least one of the received first information (41) or second information (42) to the display (30).